Manage — GBA1 Gene Therapy for Parkinson Disease
Edit fields and add or remove reviews, snapshots, outcomes, evidence claims, and documents.
Asset fields
Reviews
- Industry · concerning/low · Neurodegeneration advisor
Snapshots
None yet.
Outcomes
- Dormant · 2025-04-09
Evidence claims
- commercial / Market Size
- scientific / Differentiation
Applications
- D. Whitfield · declined · USD600,000
Funding events
None yet.
Documents
Application PDFs, reviewer forms, decks — attached as evidence (max 25 MB).
No documents yet.